Medicare Enrolled

Dr. Scott Stein, DOPA

Rheumatology · Victoria, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
605 E SAN ANTONIO ST STE 330-E, Victoria, TX 77901
3615729772
In practice since 2006 (19 years)
NPI: 1659453306 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Stein from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Stein? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Stein

Dr. Scott Stein is a rheumatology in Victoria, TX, with 19 years in practice. Based on federal Medicare data, Dr. Stein performed 89,270 Medicare services across 1,005 unique beneficiaries.

Between the years covered by Open Payments, Dr. Stein received a total of $13,683 from 45 pharmaceutical and/or device companies across 824 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Stein is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ Top 18% volume in TX$ $13,683 industry payments

Medicare Practice Summary

Medicare Utilization ↗
89,270
Medicare services
Top 18% in TX for rheumatology
1,005
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~4,698 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Certolizumab injection (Cimzia)40,000$4$13
Abatacept infusion (Orencia)24,575$34$98
Golimumab infusion (Simponi Aria)18,239$11$58
Infliximab infusion (Remicade)2,750$26$153
Denosumab injection (Prolia/Xgeva)1,620$18$43
Office visit, established patient (30-39 min)677$82$244
Administration of chemotherapy into vein, 1 hour or less568$97$263
Office visit, established patient (20-29 min)306$56$170
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle192$53$147
Administration of chemotherapy into vein, each additional hour81$20$58
Injection, methylprednisolone acetate, 40 mg81$5$23
Aspiration and/or injection of fluid large joint using ultrasound guidance53$70$192
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less40$36$132
New patient office visit (45-59 min)35$114$392
New patient office visit (30-44 min)27$69$217
Joint injection, major joint26$38$126
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
51.1% high complexity
47.7% medium
1.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$13,683
Total received (2018-2024)
Avg $1,955/year across 7 years
Top 25% in TX for rheumatology
45
Companies
824
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,628 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$55 (0.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,145
2023
$2,426
2022
$2,781
2021
$1,690
2020
$1,185
2019
$1,777
2018
$1,680

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$2,375
Aurinia Pharma U.S., Inc.
$1,382
Mallinckrodt Hospital Products Inc.
$875
AstraZeneca Pharmaceuticals LP
$844
AbbVie Inc.
$799
Radius Health, Inc.
$754
Janssen Biotech, Inc.
$690
PFIZER INC.
$682
ABBVIE INC.
$636
Horizon Therapeutics plc
$571
E.R. Squibb & Sons, L.L.C.
$557
Novartis Pharmaceuticals Corporation
$555
Lilly USA, LLC
$420
Celgene Corporation
$315
UCB, Inc.
$265
GENZYME CORPORATION
$195
AbbVie, Inc.
$170
INTERCEPT PHARMACEUTICALS, INC.
$168
Boehringer Ingelheim Pharmaceuticals, Inc.
$143
Horizon Pharma plc
$132
Mallinckrodt Enterprises LLC
$122
Merck Sharp & Dohme LLC
$98
Mallinckrodt LLC
$86
Takeda Pharmaceuticals U.S.A., Inc.
$72
ANI Pharmaceuticals, Inc.
$69
Medtronic USA, Inc.
$69
United Therapeutics Corporation
$67
Intercept Pharmaceuticals, Inc.
$63
GlaxoSmithKline, LLC.
$59
Genentech USA, Inc.
$51
Janssen Pharmaceuticals, Inc
$49
Octapharma USA, Inc.
$49
Kowa Pharmaceuticals America, Inc.
$43
IDORSIA PHARMACEUTICALS US INC
$41
Madrigal Pharmaceuticals
$33
Sandoz Inc.
$29
Neurocrine Biosciences, Inc.
$28
Exeltis, USA Inc.
$24
Azurity Pharmaceuticals, Inc.
$20
Fresenius Kabi USA, LLC
$14
Strongbridge US INC.
$14
ARBOR PHARMACEUTICALS, INC.
$14
Sobi, Inc
$14
Merck Sharp & Dohme Corporation
$13
Biohaven Pharmaceutical Holding Company Ltd.
$13
Top 3 companies account for 33.8% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · BELSOMRA · BENLYSTA · Bimzelx · COLOGUARD · COSENTYX · CYLTEZO · Cimzia · DUEXIS · EUCRISA · EVENITY · EVUSHELD · Enbrel · HUMIRA · HYRIMOZ · Horizant · Humira · IDACIO · INFLECTRA · INGREZZA · INTELLIS · KEVEYIS · KEVZARA · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · NURTEC ODT · OCALIVA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · QUVIVIQ · RAYOS · REMICADE · RESMETIROM · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STELARA · Seglentis · TALTZ · TAVNEOS · TRELEGY ELLIPTA · TREMFYA · TYVASO · Tavneos · Trintellix · Tymlos · Uloric · VPRIV · XARELTO · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $15 per 100 Medicare services performed
Looking for a rheumatology in Victoria?
Compare rheumatologys in the Victoria area by procedure volume, costs, and industry payment transparency.
Browse rheumatologys nearby

Geographic Context

Rheumatologys within 10 mi
2
Per 100K population
2.2
County median income
$70,101
Nearest hospital
CITIZENS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Stein is a mixed practice specialist, with above-average Medicare volume (top 18% in TX), and low-engagement industry engagement, with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Stein experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Stein performed 40,000 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Stein receive payments from pharmaceutical companies?
Yes. Dr. Stein received a total of $13,683 from 45 companies across 824 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Stein's costs compare to other rheumatologys in Victoria?
Dr. Stein's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Stein) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →